HealthDay – THURSDAY, May 14 (HealthDay News) — In a phase 3 clinical trial, an
experimental immune-based treatment boosted by 20 percent the overall
survival of those with tough-to-treat neuroblastoma, which affects mostly
children.
|
Whole Body Vibration Review Get information on whole body vibration systems.
|
|
HealthDay – THURSDAY, May 14 (HealthDay News) — In a phase 3 clinical trial, an
experimental immune-based treatment boosted by 20 percent the overall
survival of those with tough-to-treat neuroblastoma, which affects mostly
children.